EVOKE PHARMA, INC. Payments for Underwriting Expense
EVOKE PHARMA, INC. reported Payments for Underwriting Expense of $2.34 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForUnderwritingExpense · last filed 2014-03-25
- EVOKE PHARMA, INC. payments for underwriting expense for fiscal 2013 was $2.34M.
| Period end | Payments for Underwriting Expense 12 month |
|---|---|
| 2013-12-31 | $2.34M 10-K · filed 2014-03-25 |